1-4 of 4
Jill Ray
Close
Sort by
Journal Articles

Risk Profiling of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients By Measuring Circulating Tumor DNA

Alex F. Herrera, MD, Samuel Tracy, Brandon Croft, Stephen Opat, FRACP, FRCPA, MBBS, Jill Ray, Lisa Musick, Joseph N. Paulson, Laurie H. Sehn, MDMPH, Yanwen Jiang
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–25.
https://doi.org/10.1182/blood-2020-136645
Published: 2020
Journal Articles

BCL2 Expression Identifies a Population with Unmet Medical Need in Previously Untreated (1L) Patients with DLBCL

Edith Szafer-Glusman, Franklin V. Peale, Jr., Guiyuan Lei, Anja Mottok, Pedro Farinha, Jill Ray, Thalia A. Farazi, Martin Kornacker, Mikkel Z. Oestergaard, Juan Liu, Randy D. Gascoyne, MD, Elizabeth Punnoose
Journal: Blood
Blood (2017) 130 (Supplement 1): 418.
https://doi.org/10.1182/blood.V130.Suppl_1.418.418
Published: 2017
Journal Articles

A Simulation Analysis to Evaluate the Effect of Prospective Biomarker Testing on Progression-Free Survival (PFS) in DLBCL

Edith Szafer-Glusman, Juan Liu, Franklin V. Peale, Jr., Thalia A. Farazi, Jill Ray, Carsten Horn, Mikkel Z. Oestergaard, Martin Kornacker, Laurie H. Sehn, MDMPH, Günter Fingerle-Rowson, Jeffrey M. Venstrom, Michelle Byrtek, Elizabeth Punnoose
Journal: Blood
Blood (2017) 130 (Supplement 1): 419.
https://doi.org/10.1182/blood.V130.Suppl_1.419.419
Published: 2017
Journal Articles

Analytical Validation of Patient-Specific PCR-Based MRD Assessment for Use As a Primary Endpoint in CLL Clinical Trials

Anke Schilhabel, Henrik Knecht, Anton W. Langerak, Jacques J.M. van Dongen, Michael Kneba, Jill Ray, Elizabeth Punnoose, Doris Kim, Thomas Haberberger, Coen Bernaards, Yuda Zhu, Sock-Cheng Lewin-Koh, Matthias Ritgen
Journal: Blood
Blood (2015) 126 (23): 2924.
https://doi.org/10.1182/blood.V126.23.2924.2924
Published: 2015